Subscribe To
IO Biotech Appoints Heidi Hunter to its Board of Directors
NEW YORK, Aug. 11, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on its T-win® technology platform, announced the appointment of Heidi Hunter to its board of directors. Ms. Hunter, an accomplished global biotech leader with over 25 years of experience across the pharmaceutical value […] The post IO Biotech Appoints Heidi Hunter to its Board of Directors appeared first on ForexTV...
Read More
Posted: Aug 11 2023, 12:05
Author Name: forextv
Views: 022271